In a randomized clinical trial, three-month oral administration of ginger supplementation (3 g/d) in patients with type 2 diabetes, decreased blood glucose concentration, total anti-oxidant capacity, and paraoxonase-1 (PON-1) activity (59). Here, PON1 is linked to type 2 diabetes mellitus.